CLINICAL_TRIALS
ClinicalTrials.gov record update
SOLIRIS® (Eculizumab) for the Treatment of Participants With Coronavirus Disease 2019 (COVID 19) - An Expanded Access Program for Hospital-based Emergency Treatment
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04355494
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:16.759544+00:00
- Published At
- 2021-03-09T00:00:00+00:00
- Record Updated At
- 2021-03-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["COVID-19", "Pneumonia, Viral", "Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-03-09"- protocolSection.identificationModule.nctId
"NCT04355494"- protocolSection.identificationModule.officialTitle
"SOLIRIS\u00ae (Eculizumab) for the Treatment of Participants With Coronavirus Disease 2019 (COVID 19) - An Expanded Access Program for Hospital-based Emergency Treatment"- protocolSection.statusModule.overallStatus
"NO_LONGER_AVAILABLE"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.